David B. Weiner Inovio Pharmaceuticals, Inc. (INO) insider trading activity

David B. Weiner is Director of INOVIO PHARMACEUTICALS, INC.. Currently has a direct ownership of 82,509 shares of INO, which is worth approximately $736,805. The most recent transaction as insider was on May 15, 2024, when has been sold 2,166 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 82.5K

2.7% 3M change

91.12% 12M change

Total Value Held $736,805

David B. Weiner Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 15 2024	BUY Exercise of conversion of derivative security	-	2,166 Added 2.56%	82,509 Common Stock
Feb 26 2024	BUY Exercise of conversion of derivative security	-	2,916 Added 3.5%	80,343 Common Stock
May 16 2023	BUY Exercise of conversion of derivative security	-	19,000 Added 2.0%	929,124 Common Stock
Mar 13 2023	SELL Open market or private sale	$6,707 $1.15 p/Share	5,833 Reduced 0.64%	910,124 Common Stock
Mar 11 2023	BUY Exercise of conversion of derivative security	-	11,666 Added 1.26%	915,957 Common Stock
Feb 27 2023	SELL Open market or private sale	$14,935 $1.28 p/Share	11,668 Reduced 1.27%	904,291 Common Stock
Feb 26 2023	BUY Exercise of conversion of derivative security	-	23,334 Added 2.48%	915,959 Common Stock

Aug 11 2022	SELL Open market or private sale	$31,588 $2.66 p/Share	11,875 Reduced 1.31%	892,625 Common Stock
Aug 11 2022	BUY Exercise of conversion of derivative security	$25,650 $2.16 p/Share	11,875 Added 1.3%	904,500 Common Stock
May 16 2022	SELL Open market or private sale	$17,550 $1.95 p/Share	9,000 Reduced 1.0%	892,625 Common Stock
May 13 2022	BUY Exercise of conversion of derivative security	-	18,000 Added 1.96%	901,625 Common Stock
Mar 14 2022	SELL Open market or private sale	$13,066 $3.2 p/Share	4,083 Reduced 0.46%	883,625 Common Stock
Mar 11 2022	BUY Exercise of conversion of derivative security	-	11,667 Added 1.3%	887,708 Common Stock
Mar 09 2022	SELL Open market or private sale	$13,596 $3.33 p/Share	4,083 Reduced 0.46%	876,041 Common Stock
Mar 08 2022	BUY Exercise of conversion of derivative security	-	11,666 Added 1.31%	880,124 Common Stock
Feb 26 2022	BUY Exercise of conversion of derivative security	-	11,667 Added 1.33%	868,458 Common Stock
May 17 2021	SELL Open market or private sale	$20,158 $6.62 p/Share	3,045 Reduced 0.35%	856,791 Common Stock
May 14 2021	BUY Exercise of conversion of derivative security	-	8,700 Added 1.0%	859,836 Common Stock
Apr 21 2021	SELL Open market or private sale	$227,550 $8.56 p/Share	26,583 Reduced 3.03%	851,136 Common Stock
Apr 21 2021	BUY Exercise of conversion of derivative security	$54,000 $2.4 p/Share	22,500 Added 2.5%	877,719 Common Stock
Mar 11 2021	BUY Exercise of conversion of derivative security	-	11,667 Added 1.35%	855,219 Common Stock
Mar 09 2021	SELL Open market or private sale	$33,600 $9.6 p/Share	3,500 Reduced 0.41%	843,552 Common Stock
Mar 08 2021	SELL Open market or private sale	$32,130 $9.18 p/Share	3,500 Reduced 0.42%	835,385 Common Stock
Mar 08 2021	BUY Exercise of conversion of derivative security	-	11,667 Added 1.36%	847,052 Common Stock
Mar 05 2021	BUY Exercise of conversion of derivative security	-	11,666 Added 1.37%	838,885 Common Stock

DBW

David B. Weiner

Director

Plymouth Meeting, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INO shares.

Notify only if

Value

Insider Trading

Get notified when an Inovio Pharmaceuticals, Inc. insider buys or sells INO shares.

Notify only if

Operation

Value

Type

News

Receive news related to INOVIO PHARMACEUTICALS, INC.

Track Activities on INO

Account